Chemotherapy – Education

Breast Cancer Awareness Month 2020: Nearly 30% of Breast Cancer Patients Gain Weight After Receiving Chemotherapy

Washington, October 25: Nearly 30 per cent patients with breast cancer gained weight after receiving chemotherapy treatment, suggested a study. The study was published in the journal BMC Medicine. Beyond weight gain, chemotherapy is also known to increase the risk of high blood pressure and glucose intolerance, a prediabetes condition. Although this is a familiar… Read More »

FDA Approves Opdivo (nivolumab) for the Treatment of Patients with Advanced Esophageal Squamous Cell Carcinoma (ESCC) After Prior Fluoropyrimidine- and Platinum-based Chemotherapy

Print this page PRINCETON, N.J.–(BUSINESS WIRE) June 10, 2020 Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.1 This application was granted… Read More »